Abstract
Undifferentiated nasopharyngeal carcinoma (NPC) is closely associated with EBV infection, and the EBV-encoded latent membrane protein 1 (LMP1) is frequently detected in NPC. However, little is known about the pathologic roles of LMP1 in this disease. Recently, we reported the morphologic transformation and increased expression of the LAMC2 and ITGα6 genes in LMP1-expressing NPC cell lines. In this study, we further examine the effects of LMP1 in an immortalized nasopharyngeal epithelial cell line called NP69. This cell line was established from primary nonmalignant nasopharyngeal epithelial cells and may represent a model of premalignant nasopharyngeal epithelial cells. LMP1 induced many phenotypic changes in NP69 cells. These include morphologic transformation, increased cell proliferation, anchorage-independent growth, resistance to serum free–induced cell death, and enhanced cell migration and invasion. In addition, expression array analysis identified 28 genes that demonstrated a more than 2-fold difference in expression of NP69 cells expressing LMP1 when compared with a vector control. Two of the up-regulated genes (VEGF and vimentin) identified have been previously reported as LMP1 targets. The majority of the identified genes are associated with cell growth, differentiation, cell shape, and invasion. The present findings support the proposed roles of LMP1 in promoting cell transformation, migration, and invasion in premalignant nasopharyngeal epithelial cells. The present study also indicates the activation of the Ras/MAPK pathway in LMP1-expressing cells, which may be involved in mediating some of the transforming effects of LMP1 observed in nasopharyngeal epithelial cells.
Similar content being viewed by others
Introduction
The poorly differentiated or undifferentiated nasopharyngeal carcinoma (NPC) is common in Southern China. This cancer is characterized by a high incidence of lymph node metastasis (Sham et al, 1990) and is closely associated with EBV infection (Rickinson and Kieff, 1996). A causal role of EBV in NPC has been suggested, and the EBV-encoded latent membrane protein 1 (LMP1) is believed to be important in mediating the transformation properties of EBV in NPC development. LMP1 is detected in about 65% of EBV-positive NPC (Fahraeus et al, 1988). A clinical study of NPC has shown that LMP1-positive tumors are more progressive than LMP1-negative tumors in growth and prone to invade lymph nodes (Hu et al, 1995). In in vitro studies, LMP1 is essential for EBV-induced immortalization of B lymphocytes. LMP1 is also able to transform fibroblasts (Rickinson and Kieff, 1996) and induce various phenotypic changes in epithelial cells (Dawson et al, 1990; Rickinson and Kieff, 1996). LMP1 may also be involved in metastasis of tumor cells by induction of matrix metallo-proteinase-9 (MMP-9) (Yoshizaki et al, 1998), Ets1 (Kim et al, 2000), and COX-2 (Murono et al, 2001) as well as reduction of E-cadherin expression (Fahraeus et al, 1992). However, few studies have been conducted to investigate the effects of LMP1 in nasopharyngeal epithelial cells, which are the natural host cells of EBV infection. In our previous study of LMP1 in NPC cells, we observed that LMP1 could induce morphologic transformation and increase expression of ITGα6 and LAMC2, which may facilitate tumor metastasis (Lo et al, 2001a). To further determine the pathologic effect of LMP1 in NPC, a detailed study of the effects of LMP1 on the biologic properties and gene expression profile in an SV40T-immortalized nasopharyngeal epithelial cell line, NP69, established in our laboratory (Tsao et al, 2002) were investigated.
Results
LMP-Induced Morphologic Change in NP69 Cells
Expression of LMP1 in NP69 cells induced a morphologic change from a typical epithelial cobblestone to an elongated and fibroblastoid shape. The NP69-LMP1 cells also grew in a scattered pattern with a marked reduction in cell-cell contact (Fig. 1).
LMP1 Increased Cell Proliferation and Reduced Serum Dependence
In medium supplemented with growth factors, the NP69-LMP1 cells have a shorter doubling time (66 hours) compared with control NP69-pLNSX cells (87 hours doubling time) (Fig. 2A). Cell cycle analysis also indicated that the proportion of S phase cells in NP69-LMP1 (34%) was higher than that in the NP69-pLNSX control (24%) (Fig. 2, C and D). When growth factors were withdrawn from the medium, NP69-LMP1 cells were more resistant to cell death and their proliferation could still be detected at Day 7, with an average doubling time of 123 hours (Fig. 2B). In contrast, the control NP69-pLNSX cells underwent growth arrest by Day 7, with a marked decrease in cell numbers (Fig. 2B). Also, after removal of growth factors for 36 hours, a marked reduction in the percentage of S phase cells in control NP69-pLNSX (16%) (Fig. 2E) compared with NP69-LMP1 cells (48%) was detected (Fig. 2F). Both NP69-LMP1 and NP69-pLNSX cells eventually underwent cell death after prolonged growth in medium without growth factors.
LMP1 Enhanced Anchorage-Independent Growth
In soft agar assay (Fig. 3), the NP69-LMP1 cells were able to undergo anchorage-independent growth by forming 42 colonies, of an average 5 × 104 cells (Table 1). In contrast, the control NP69-pLNSX cells failed to form any colonies in three independent experiments (Table 1).
LMP1-Induced Cell Migration and Invasion
In a scrape-wound migration assay, the NP69-LMP1 cells migrated to the wound surface on the plastic dish after 10 hours, forming an uneven growth edge (Fig. 4, C and D). By contrast, the control NP69-pLNSX cells demonstrated slower migration ability and the wound edge remained smooth (Fig. 4, A and B). In a collagen gel invasion assay, after growing the cells for 8 days, the control NP69-pLNSX cells formed spheroid shapes inside the collagen gel matrix (Fig. 4E), which is typical of noninvasive cells. By contrast, the NP69-LMP1 cells formed branching tubules through the collagen gel (Fig. 4F), which is commonly observed in cells with high invasive properties. In a Boyden chamber invasion assay (Fig. 5A), the number of NP69-LMP1 cells passing through the matrigel coated membrane was about 5-fold more than that of control cells (Fig. 5B) after 24 hours of incubation.
Determination of Gene Expression Profiles of LMP1-Expressing NP69 Cells by cDNA Array
The gene expression profile of NP69-LMP1 cells was examined by Atlas Human Cancer 1.2 arrays (Clontech) and was compared with that of the control NP69-pLNSX cells at similar passage numbers. A total of 28 genes showed significant change of expression level in NP69-LMP1 cells (>2-fold difference). Seventeen genes were overexpressed, whereas 11 were suppressed (Tables 2 and 3).
Confirmation of Differentially Expressed Genes Identified in LMP1-Expressing Cells
By quantitative real-time RT-PCR, the up-regulation of VEGF, ET2, RAD, RhoGDI-2, MT3-MMP, FN1, Axl and its ligand, Gas6, as well as the down-regulation of K14, K19, Notch1, and JAG2 was confirmed in NP69-LMP1 cells (Fig. 6). Overexpression and down-regulated expression of these genes were also observed in at least two of the four NPC cell lines (CNE1, CNE2, SUNE1, and HK1) expressing LMP1 (Fig. 6).
Western Blot Analysis of LMP1-Expressing Cells
By Western blotting (Fig. 7), stable expression of the LMP1 protein in all LMP1-infected cell lines was confirmed. In addition, protein expression of vimentin and VEGF was increased in LMP1-expressing NP69 and in at least two of four NPC cell lines expressing LMP1 when compared with their control counterparts. Protein expression of E-cadherin was decreased in LMP1-expressing NP69, CNE1 and CNE2 cell lines. Furthermore, using antibodies specific to phosphorylated kinases of the Raf/MAPK signal pathway, Western blot analysis indicated the activation of Raf, MEK1/2, and Erk1/2 kinases in LMP1-expressing NP69 and two NPC cells lines (CNE1 and SUNE1) expressing LMP1 (Fig. 8).
Discussion
This is the first article that uses an immortalized nasopharyngeal epithelial cell line (NP69) system to study the pathologic role of LMP1 in NPC development. The immortalized NP69 cells were established from primary culture of nonmalignant nasopharyngeal epithelial cells that had not been infected and modified by EBV. They are nontumorigenic in nude mice and do not exhibit anchorage-independent growth in soft agar (Tsao et al, 2002). Thus, they provide a good model for examining the biologic properties of EBV genes including LMP1. In this study, we demonstrated that LMP1 could induce many phenotypic changes in NP69 cells. By cDNA array analysis, the gene expression profile of NP69 cells expressing LMP1 was determined (Table 2 and 3). To reduce the chances of false-positive results, only those genes that demonstrated at least a 2-fold difference in expression between NP69 cells expressing LMP1 and their empty vector control cells were considered. Consistent with previous studies of other workers, two of the up-regulated genes (VEGF and vimentin) identified here (Table 2) have been demonstrated to be induced by LMP1 (Birkenbach et al, 1989; Murono et al, 2001). The identification of two known LMP1 target genes provided some validation of our experimental approach. Interestingly, the majority of the differentially expressed genes identified correlated with the biologic alterations observed in NP69-LMP1 cells. Our present findings support a major role of LMP1 in enhancing survival and malignant properties in premalignant nasopharyngeal epithelial cells. The significance of these differentially expressed genes, their relationships with the biologic changes in NP69-LMP1 cells, and the possible involvement of these genes in the pathogenesis of NPC are discussed below.
Cell Growth and Survival
In this study, LMP1 expression in NP69 cells induced cell proliferation and enhanced resistance to serum free–induced apoptosis (Fig. 2). These observations are in line with previous reports showing that LMP1 reduced serum dependence in human keratinocytes (Hu et al, 1993) and Jurkat T cells (Kawanishi, 1997), although the mechanisms involved are not clear. Here, both Axl and Gas6 were demonstrated to be up-regulated by LMP1 (Fig. 6). Axl is a receptor tyrosine kinase that can induce cellular proliferation and transformation after binding with its ligand, Gas6 (Mark et al, 1996). The increased expression of Axl and Gas6 may contribute to the higher proliferation rate and enhanced survival ability upon withdrawal of growth factors observed in NP69-LMP1 cells. Further study is warranted to confirm the involvement of this pathway in cell growth and survival of LMP1-expressing nasopharyngeal epithelial cells.
Epithelial Mesenchymal Transformation
The effect of LMP1 in morphologic alterations has been noted previously in human epithelial cells (Fahraeus et al, 1990). Our present data also indicated a spindle shape and scattered growth pattern in LMP1-expressing NP69 cells (Fig. 1). The mechanism involved in this morphologic change induced by LMP1 is poorly understood. Interestingly, we observed altered gene expression of some cytoskeletal proteins and their associated proteins in NP69-LMP1 cells. These include down-regulation of keratin 14 (K14), keratin 19 (K19), desmoplakin I and II and desmocollin 3A/3B as well as up-regulation of vimentin (Tables 2 and 3). Cytokeratins are the common intermediate filaments expressed in epithelial cells, including nasopharyngeal epithelium. Their association with cell adhesion structures such as desmoplakin and desmocollin are involved in maintaining cell shape and adhesion in epithelial cells. Down-regulation of these cytoskeleton-associated proteins may contribute to the altered morphology observed in LMP1-expressing NP69 cells. In contrast, vimentin, which is predominantly a mesenchymal skeletal protein commonly expressed in fibroblasts, was up-regulated in NP69-LMP1 cells (Fig. 7). In this study, the up-regulation of vimentin and the down-regulation of K14 and K19 in LMP1-expressing nasopharyngeal epithelial cells suggest that LMP1 facilitates the switch of intermediate filament expression from cytokeratins to vimentin, an epithelial-mesenchymal transformation (EMT) process commonly observed in tumor invasion and metastasis (Portella et al, 1998). The underlying mechanism of this mesenchymal transformation induced by LMP1 is unknown. Some studies have indicated that transforming growth factor-β (TGF-β) is involved in the EMT process in normal mammary epithelial cells, which is accompanied by reorganization of cytoskeleton and decreased expression of E-cadherin and cytokeratins but increased expression of vimentin (Miettinen et al, 1994). TGFβ and TGFβ2 were also up-regulated by LMP1 in this study (Table 2). Together with findings by Western blotting that E-cadherin was reduced in LMP1-expressing cells (Fig. 7), the EMT change mediated by LMP1 expression may facilitate invasion in premalignant nasopharyngeal epithelial cells.
Cell Migration and Invasion
The invasive property of NP69-LMP1 cells was indicated by their high rate of invasion and migration (Figs. 4 and 5). In particular, the invasion process involves degradation of the extracellular matrix in which proteinase must be produced. Increased expression of MMP-9 proteinase by LMP1 has been reported previously (Yoshizaki et al, 1998) and has been indicated in LMP1-positive NPC tissues (Horikawa et al, 2000). Additionally, the increased expression of MT3-MMP in LMP1-expressing nasopharyngeal epithelial cells was observed in the present study (Fig. 6). The MT3-MMP is a membrane-bound matrix metalloproteinase and is capable of degrading extracellular matrix (Takino et al, 1995). It also possesses the potential to mediate the growth and invasion behavior of cancer cells in vivo (Kitagawa et al, 1999). Kang et al (2000) have reported that overexpression of MT3-MMP enhances the invasive growth of MDCK cells in collagen gels. MT3-MMP may be another target of LMP1 in enhancing the invasive property of NPC cells.
Cell Differentiation
We report here for the first time, the down-regulation of Jagged 2 and Notch1 in LMP1-expressing nasopharyngeal epithelial cells (Fig. 6). Jagged family proteins are ligands of Notch receptors. Jagged/Notch signaling is important in regulating the balance between cell differentiation and stem cell proliferation (Artavanis-Tsakonas et al, 1999). Previous study has indicated that inhibiting mouse Notch1 expression prevents hormone-induced differentiation of 3T3-L1 cells (Ruiz-Hidalgo et al, 1999). Another study in transgenic mice has also shown that deletion of the Notch1 gene resulted in deregulated expression of multiple differentiation markers and marked epithelial hyperplasia, which are early steps of the carcinogenic process (Rangarajan et al, 2001). EBV infection is closely associated with the undifferentiated and poorly differentiated NPC. Inhibition of terminal differentiation of epithelial cells and reduction of keratin expression had been reported in human epithelial cell lines expressing LMP1 (Dawson et al, 1990; Fahraeus et al, 1990). Previous study in LMP1 transgenic mice has also shown that LMP1 could induce hyperplasia in epidermis (Wilson et al, 1990). It would be interesting to determine whether Jagged/Notch is a target pathway disrupted by LMP1 to deregulate the normal differentiation process, which may promote tumor progression.
In line with the inhibition of differentiation by LMP1, reduced expression of keratins (K14 and K19) was observed in LMP1-expressing cells (Fig. 6). Keratins are commonly used as differentiation markers and specific types of keratins are expressed in epithelial cells at different stages of differentiation. Alteration of keratin expression is common in neoplasms because of a deranged differentiation program (van der Velden et al, 1993). A previous report has shown the absence of K5/K14 antibody staining in preinvasive and most invasive breast carcinomas (Jarasch et al, 1988). Loss of K19 had also been reported in dedifferentiated MDCK-C7 cells (Pollack et al, 1997). In addition, weak expression of K19 was found in poorly differentiated carcinoma of the stomach (Stammberger and Baczako, 1999). In this study, reduction of K14 and K19 as well as JAG2 and Notch1 in LMP1-expressing cells implies a close association of LMP1 with the undifferentiated phenotype of nasopharyngeal epithelial cells. It remains to be determined whether LMP1 directly induced the undifferentiated phenotype of nasopharyngeal epithelial cells or the association is a result of clonal expansion of undifferentiated clones expressing LMP1.
Activation of Ras/MAPK Signal Activation
The identification of VEGF, fibronectin, and Gas6 as LMP1 up-regulated genes (Fig. 6) was of particular interest. Expression of these three genes has been indicated in Ras/MAPK signal activation (Danen and Yamada, 2001; Goruppi et al, 1999; Yu and Sato, 1999), suggesting that LMP1 is able to activate the Ras/MAPK signal pathway. In an earlier study, LMP1 was proposed to be functionally similar to activated Ras in cellular transformation (Dawson et al, 1990). Activation of the Ras/MAPK pathway by LMP1 has also been reported to be essential for cellular transformation of rodent fibroblasts (Roberts and Cooper, 1998). In the present study, the Ras/MAPK signal kinases—Raf, MEK and Erk—were activated in LMP1-expressing nasopharyngeal epithelial cells (Fig. 8). The activation of the Ras/MAPK signal pathway by LMP1 may mediate some of the transformation properties of NP69-LMP1 cells, notably the anchorage-independent growth and enhanced proliferation.
Interestingly, the cDNA array hybridization used in our system was able to detect differential expression of some but not all of the other genes previously reported to be up-regulated by LMP1. For example, up-regulation of VEGF and vimentin expression by LMP1, which have been previously reported (Birkenbach et al, 1989; Murono et al, 2001), were detected in NP69-LMP1 cells by the cDNA array but not epithelial growth factor receptor, MMP-9, and IL-8 (Eliopoulos et al, 1999; Fahraeus et al, 1992; Miller et al, 1998). One explanation is that SV40T in the immortalized nasopharyngeal epithelial cells may also affect the expression levels of these genes and mask the effect of LMP on their expression. However, using RT-PCR, we were able to confirm the up-regulated expression of these genes in NP69-LMP1 (data not shown). Similarly, down-regulation of E-cadherin, which has also been reported to be a downstream event of LMP1 (Yoshizaki et al, 1998), was also confirmed in NP69-LMP1 cells by Western blotting (Fig. 7) but not by cDNA array. This suggests that the cDNA array hybridization may have limitations in detecting low copy differences in the cellular mRNA level.
In summary, using an immortalized nasopharyngeal epithelial cell line model, we have demonstrated the relationship between biologic alterations and differentially expressed genes induced by LMP1. The present findings support the major role of LMP1 in enhancing cell survival and promoting tumor invasion in nasopharyngeal epithelial cells. This is also supported by clinical observation of the high expression of LMP1 in premalignant lesions of NPC (Pathmanathan et al, 1995), which may facilitate their conversion into invasive NPC cells.
Materials and Methods
Cell Lines
The SV40T-immortalized nasopharyngeal epithelial cell line (NP69) was grown in low calcium (0.1 mm) MCDB151 medium supplemented with 1% dialyzed fetal bovine serum and other growth supplements. Details of the growth medium used in this cell line have been described previously (Tsao et al, 2002). The NPC cell lines, CNE1, CNE2, SUNE1 (Teng et al, 1996) (kindly provided by Dr. Z. Zheng, Zhong Shan Medical Science University), and HK1 (Huang et al, 1980), were routinely maintained in RPMI 1640 supplemented with 10% fetal bovine serum.
Expression of LMP1
LMP1 expression in NP69 cells was achieved by infecting the cells with pLNSX-LMP1 retrovirus. Control cells were infected with the empty vector pLNSX at the same passage number. The retroviral vector expressing LMP1 (pLNSX-LMP1) was kindly provided by Dr. L. Cao, University of Hong Kong (Yang et al, 2000). The retroviral infection of LMP1 in nasopharyngeal epithelial cells has been previously described (Lo et al, 2001a). The successfully infected cells were selected by 400 μg/ml of G418, and the resistant clones were pooled and designated as NP69-LMP1. Expression of LMP1 in the resistant clones was confirmed by Western blotting (Fig. 7). Control cells infected with the pLNSX vector were designated as NP69-pLNSX.
Cell Cycle Analysis
Cell cycle analysis was performed on an Epic Elite flow cytometer (Beckman-Coulter) and analyzed using the ModFit LT2.0 software (Coulter, Hialeah, Florida). Cells (5 × 105) were fixed in ice-cold 70% ethanol for at least 1 hour. Before analysis, fixed cells were washed with PBS, treated with RNase (1 μg/ml), and stained with propidium iodide (50 μg/ml) for 30 minutes at 37° C.
Growth Curve Analysis
For growth curve analysis, 2 × 105 cells per well were inoculated onto a 24-well plate. The cells were trypsinized every 1 or 2 days, and the number of viable cells was counted with the trypan blue exclusion method.
Soft Agar Cloning Assay
For soft agar assay, the cells were seeded into semisolid agar medium (base layer, 0.6%; upper layer, 0.3%) at a density of 5 × 103 cells per well in 6-well plates. After 3 weeks of incubation at 37° C with 5% CO2, the number of colonies formed was determined.
Scrape-Wound Migration Assay
For scrape-wound migration assay, confluent cultures grown on 6-well plates were scraped with a yellow pipette tip to make a wound. The scraped culture was maintained in serum-free medium to slow the growth rate. The morphology of individual cells in the migrating front was monitored at 8 to 12 hours under a phase-contrast microscope.
Boyden Chamber Invasion Assay
The Boyden chamber invasion assay was performed using a transwell chamber (6.4 mm in diameter with 8.0-μm pore size; Millipore) coated with Matrigel (Becton Dickinson) according to a previously published method (Albini et al, 1987). Cells (5 × 104) in 200 μl of serum-free medium with 0.1% BSA were inoculated into a chamber that was put into a well of a 24-well plate. After 24 hours of incubation, the cells migrating on the lower surface were fixed in methanol and stained with hematoxylin and eosin.
Collagen Gel Invasion Assay
For collagen gel assay, a collagen mixture was prepared by mixing seven volumes of ice-cold type I collagen solution (Collaborative Research) with two volumes of 5× concentrated culture medium and one volume of 0.05 N NaOH containing 2.2% NaHCO3 and 200 mm HEPES. Cells were suspended in this collagen mixture at 5 × 104 cells/ml. After gel setting, the cells were maintained in medium with growth factors. The pattern of the colony was examined and photographed at Day 8.
Western Blotting
The detailed procedures of Western blotting have been described previously (Lo et al, 2001b). Briefly, the cells were lysed in cell lysis buffer (Cell Signaling). The cell lysates (25–100 μg of protein) were separated in 10% SDS-PAGE and then electrophoretically transferred to a nitrocellulose membrane (BioRad, Richmond, California) for blotting. The primary antibodies used were LMP1 (1:1000 dilution; Dako, Carpinteria, California), E-cadherin (1:2000), c-Raf (1:1000; Transduction Laboratories (Lexington, Kentucky), vimentin (1:100; Sigma, St. Louis, Missouri), VEGF (1:100; Santa Cruz Biochemicals, Santa Cruz, California), phospho-Raf, phospho-MEK1/2, and phospho-Erk1/2 (Cell Signaling). All phospho-antibodies were diluted 1:1000.
cDNA Array Hybridization
Atlas Human Cancer 1.2 Arrays (Clontech, Palo Alto, California) containing 1176 genes were used in this study to identify the gene expression profiles of the LMP1-expressing NP69 cells. Total RNA was isolated using TRIzol reagent (Invitrogen, San Diego, California). RNA was then treated with DNase I (Invitrogen) to remove DNA contamination. Preparation and hybridization of radioactively labeled cDNA from total RNA were performed according to the protocol provided by Clontech. The hybridization signal was detected with a PhosphorImager, and the signal intensity at each cDNA spot was quantified using AltasImage 1.01 software (Clontech). Signal intensities were calculated by subtracting the background signal and then normalized to the spots of positive controls on the array.
Quantitative Real-Time RT-PCR
First-strand cDNA was synthesized from DNase-treated total RNA with oligo-dT primer and SuperScript II reverse transcriptase (Invitrogen), followed by PCR amplification using the corresponding gene-specific primers. Primer sequences are as follows: (a) 5′-CGGAATCTGGTCATCAAGGT-3′ (sense) and 5′-AGGGTTTATAGGCTGCACGA-3′ (antisense) for Gas6; (b) 5′-GGGATCCACTGTGAGAACAA (sense) and 5′-CACACCAGTGCACAAGGTTC-3′ (antisense) for Notch1; and (c) 5′-CCGCAGACGTGTAAAT-GTTCCT-3′ (sense) and 5′-CGGCTTGTCACATCTGC-AAGTA-3′ (antisense) for VEGF. For other gene-specific primers used in this study, the primer sequence information was acquired from Clontech. Expression of GAPDH (5′-CTCAGACACCATGGGGAA-3′ (sense) and 5′-ATGATCTTGAGGCTGTTG-3′ (antisense)) was used as an internal control. Real-time PCR was performed in a 25-μl reaction, which included 1 μl of cDNA template, 50 mm KCl, 1.5 to 3 mm MgCl2, 10 mm Tris-HCl, pH 9.0, 0.05 mm of each dNTP, 0.2 mm of each forward and reverse oligo primer, 2.5 U of Taq DNA polymerase (Amersham, Arlington Heights, Illinois), and 0.1× SYBR Green I (Molecular Probes, Eugene, Oregon), using an iCycler iQ Multi-Color Real Time PCR Detection System (BioRad). Each PCR reaction was optimized to ensure that a single PCR product was amplified and no product corresponding to primer-dimer pairs was present. PCR reactions of each template were performed in duplicate in one 96-well plate for each pair of gene-specific primers. The PCR cycling conditions were as follows: 95° C for 3 minutes followed by 50 cycles of three steps at 95° C for 30 seconds, gene-specific annealing temperature for 30 seconds, and then 72° C for 30–40 seconds.
The relative fold change method was used to determine the relative quantitative gene expression for each gene studied compared with the GAPDH control (Winer et al, 1999). The relative fold change or relative gene expression value = 2−ΔΔCt, where ΔΔCt = (CtTarget[LMP1] − CtGAPDH[LMP1]) − (CtTarget[pLNSX] − CtGAPDH[pLNSX]). CtTarget[LMP1] = threshold cycle of the target gene examined in the LMP1-expressing cells; CtGAPDH[LMP1] = threshold cycle of the GAPDH gene in the LMP1-expressing cells; CtTarget[pLNSX] = threshold cycle of the target gene examined in the control vector pLNSX cells; and CtGAPDH[pLNSX] = threshold cycle of the GAPDH gene in the control vector pLNSX cells.
References
Albini A, Iwamoto Y, Kleinman HK, Martin GR, Aaronson SA, Kozlowski JM, and McEwan RN (1987). A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 47: 3239–3245.
Artavanis-Tsakonas S, Rand MD, and Lake RJ (1999). Notch signaling: Cell fate control and signal integration in development. Science 284: 770–776.
Birkenbach M, Liebowitz D, Wang F, Sample J, and Kieff E (1989). Epstein-Barr virus latent infection membrane protein increases vimentin expression in human B-cell lines. J Virol 63: 4079–4084.
Danen EH and Yamada KM (2001). Fibronectin, integrins, and growth control. J Cell Physiol 189: 1–13.
Dawson CW, Rickinson AB, and Young LS (1990). Epstein-Barr virus latent membrane protein inhibits human epithelial cell differentiation. Nature 344: 777–780.
Eliopoulos AG, Gallagher NJ, Blake SM, Dawson CW, and Young LS (1999). Activation of the p38 mitogen-activated protein kinase pathway by Epstein-Barr virus-encoded latent membrane protein 1 coregulates interleukin-6 and interleukin-8 production. J Biol Chem 274: 16085–16096.
Fahraeus R, Chen W, Trivedi P, Klein G, and Obrink B (1992). Decreased expression of E-cadherin and increased invasive capacity in EBV-LMP-transfected human epithelial and murine adenocarcinoma cells. Int J Cancer 52: 834–838.
Fahraeus R, Fu HL, Ernberg I, Finke J, Rowe M, Klein G, Falk K, Nilsson E, Yadav M, and Busson P (1988). Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma. Int J Cancer 42: 329–338.
Fahraeus R, Rymo L, Rhim JS, and Klein G (1990). Morphological transformation of human keratinocytes expressing the LMP gene of Epstein-Barr virus. Nature 345: 447–449.
Goruppi S, Ruaro E, Varnum B, and Schneider C (1999). Gas6-mediated survival in NIH3T3 cells activates stress signalling cascade and is independent of Ras. Oncogene 18: 4224–4236.
Horikawa T, Yoshizaki T, Sheen TS, Lee SY, and Furukawa M (2000). Association of latent membrane protein 1 and matrix metalloproteinase 9 with metastasis in nasopharyngeal carcinoma. Cancer 89: 715–723.
Hu LF, Chen F, Zhen QF, Zhang YW, Luo Y, Zheng X, Winberg G, Ernberg I, and Klein G (1995). Differences in the growth pattern and clinical course of EBV-LMP1 expressing and non-expressing nasopharyngeal carcinomas. Eur J Cancer 31A: 658–660.
Hu LF, Chen F, Zheng X, Ernberg I, Cao SL, Christensson B, Klein G, and Winberg G (1993). Clonability and tumorigenicity of human epithelial cells expressing the EBV encoded membrane protein LMP1. Oncogene 8: 1575–1583.
Huang DP, Ho JH, Poon YF, Chew EC, Saw D, Liu MC, Li CL, Mak JM, Lai SH, and Lau WH (1980). Establishment of a cell line (NPC/HK1) from a differentiated squamous carcinoma of nasopharynx. Int J Cancer 26: 127–132.
Jarasch ED, Nagle RB, Kaufmann M, Maurer C, and Bocker WJ (1988). Differential diagnosis of benign epithelial proliferations and carcinomas of the breast using antibodies to cytokeratins. Hum Pathol 19: 276–289.
Kang T, Yi J, Yang W, Wang X, Jiang A, and Pei D (2000). Functional characterization of MT3-MMP in transfected MDCK cells: Progelatinase A activation and tubulogenesis in 3-D collagen lattice. FASEB J 14: 2559–2568.
Kawanishi M (1997). Expression of Epstein-Barr virus latent membrane protein 1 protects Jurkat T cells from apoptosis induced by serum deprivation. Virology 228: 244–250.
Kim KR, Yoshizaki T, Miyamori H, Hasegawa K, Horikawa T, Furukawa M, Harada S, Seiki M, and Sato H (2000). Transformation of Madin-Darby canine kidney (MDCK) epithelial cells by Epstein-Barr virus latent membrane protein 1 (LMP1) induces expression of Ets1 and invasive growth. Oncogene 19: 1764–1771.
Kitagawa Y, Kunimi K, Uchibayashi T, Sato H, and Namiki M (1999). Expression of messenger RNAs for membrane-type 1, 2, and 3 matrix metalloproteinases in human renal cell carcinomas. J Urol 162: 905–909.
Lo AKF, Liu Y, Wang X, Wong YC, Lee CK, Huang DP, and Tsao SW (2001a). Identification of downstream target genes of latent membrane protein 1 in nasopharyngeal carcinoma cells by suppression subtractive hybridization. Biochim Biophys Acta 1520: 131–140.
Lo AKF, Yuen PW, Liu Y, Wang XH, Cheung ALM, Wong YC, and Tsao SW (2001b). Downregulation of hemidesmosomal proteins in nasopharyngeal carcinoma cells. Cancer Lett 163: 117–124.
Mark MR, Chen J, Hammonds RG, Sadick M, and Godowsk PJ (1996). Characterization of Gas6, a member of the superfamily of G domain-containing proteins, as a ligand for Rse and Axl. J Biol Chem 271: 9785–9789.
Miettinen PJ, Ebner R, Lopez AR, and Derynck R (1994). TGF-beta induced transdifferentiation of mammary epithelial cells to mesenchymal cells: Involvement of type I receptors. J Cell Biol 127: 2021–2036.
Miller WE, Cheshire JL, Baldwin AS Jr, and Raab-Traub N (1998). The NPC derived C15 LMP1 protein confers enhanced activation of NF-kappa B and induction of the EGFR in epithelial cells. Oncogene 16: 1869–1877.
Murono S, Inoue H, Tanabe T, Joab I, Yoshizaki T, Furukawa M, and Pagano JS (2001). Induction of cyclooxygenase-2 by Epstein-Barr virus latent membrane protein 1 is involved in vascular endothelial growth factor production in nasopharyngeal carcinoma cells. Proc Natl Acad Sci USA 98: 6905–6910.
Pathmanathan R, Prasad U, Sadler R, Flynn K, and Raab-Traub N (1995). Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma. N Engl J Med 333: 693–698.
Pollack V, Scheiber K, Pfaller W, and Schramek H (1997). Loss of cytokeratin expression and formation of actin stress fibers in dedifferentiated MDCK-C7 cell lines. Biochem Biophys Res Commun 241: 541–547.
Portella G, Cumming SA, Liddell J, Cui W, Ireland H, Akhurst RJ, and Balmain A (1998). Transforming growth factor beta is essential for spindle cell conversion of mouse skin carcinoma in vivo: Implications for tumor invasion. Cell Growth Differ 9: 393–404.
Rangarajan A, Talora C, Okuyama R, Nicolas M, Mammucari C, Oh H, Aster JC, Krishna S, Metzger D, Chambon P, Miele L, Aguet M, Radtke F, and Dotto GP (2001). Notch signaling is a direct determinant of keratinocyte growth arrest and entry into differentiation. EMBO J 20: 3427–3436.
Rickinson AB and Kieff E (1996). Epstein-Barr virus. In: Fields BN, Knipe DM, and Howley PM, editors. Fields virology. Philadelphia: Lippincott-Raven, 2397–2446.
Roberts ML and Cooper NR (1998). Activation of a ras-MAPK-dependent pathway by Epstein-Barr virus latent membrane protein 1 is essential for cellular transformation. Virology 240: 93–99.
Ruiz-Hidalgo MJ, Garces C, and Laborda J (1999). Notch-1 expression levels in 3T3-L1 cells influence ras signaling and transformation by oncogenic ras. Int J Oncol 14: 777–783.
Sham JS, Choy D, and Wei WI (1990). Nasopharyngeal carcinoma: Orderly neck node spread. Int J Radiat Oncol Biol Phys 19: 929–933.
Stammberger P and Baczako K (1999). Cytokeratin 19 expression in human gastrointestinal mucosa during human prenatal development and in gastrointestinal tumours: Relation to cell proliferation. Cell Tissue Res 298: 377–381.
Takino T, Sato H, Shinagawa A, and Seiki M (1995). Identification of the second membrane-type matrix metalloproteinase (MT-MMP-2) gene from a human placenta cDNA library: MT-MMPs form a unique membrane-type subclass in the MMP family. J Biol Chem 270: 23013–23020.
Teng ZP, Ooka T, Huang DP, and Zeng Y (1996). Detection of Epstein-Barr virus DNA in well and poorly differentiated nasopharyngeal carcinoma cell lines. Virus Genes 13: 53–60.
Tsao SW, Wong X, Liu Y, Cheung ALM, Feng H, Zheng Z, Wong N, Yuen PW, Lo AKF, Wong YC, and Huang DP (2002). Establishment of two immortalized nasopharyngeal epithelial cell lines using SV40 large T and HPV16E6/E7 viral oncogenes. Biochim Biophys Acta 1590: 150–158.
van der Velden LA, Schaafsma HE, Manni JJ, Ramaekers FC, and Kuijpers W (1993). Cytokeratin expression in normal and (pre)malignant head and neck epithelia: An overview. Head Neck 15: 133–146.
Wilson JB, Weinberg W, Johnson R, Yuspa S, and Levine AJ (1990). Expression of the BNLF-1 oncogene of Epstein-Barr virus in the skin of transgenic mice induces hyperplasia and aberrant expression of keratin 6. Cell 61: 1315–1327.
Winer J, Jung CK, Shackel I, and Williams PM (1999). Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro. Anal Biochem 270: 41–49.
Yang X, Sham JS, Ng MH, Tsao SW, Zhang D, Lowe SW, and Cao L (2000). LMP1 of Epstein-Barr virus induces proliferation of primary mouse embryonic fibroblasts and cooperatively transforms the cells with a p16-insensitive CDK4 oncogene. J Virol 74: 883–891.
Yoshizaki T, Sato H, Furukawa M, and Pagano JS (1998). The expression of matrix metalloproteinase 9 is enhanced by Epstein-Barr virus latent membrane protein 1. Proc Natl Acad Sci USA 95: 3621–3626.
Yu Y and Sato JD (1999). MAP kinases, phosphatidylinositol 3-kinase, and p70 S6 kinase mediate the mitogenic response of human endothelial cells to vascular endothelial growth factor. J Cell Physiol 178: 235–246.
Acknowledgements
This study was supported by the Research Grant Council, Hong Kong (HKU7356/02M) and a research retreat grant (Faculty of Medicine, HKU) awarded to SWT. DPH is supported by the Institute of Molecular Oncology at the Chinese University of Hong Kong and the Kadoorie Charitable Foundations.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lo, A., Liu, Y., Wang, X. et al. Alterations of Biologic Properties and Gene Expression in Nasopharyngeal Epithelial Cells by the Epstein-Barr Virus–Encoded Latent Membrane Protein 1. Lab Invest 83, 697–709 (2003). https://doi.org/10.1097/01.LAB.0000067480.44925.10
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1097/01.LAB.0000067480.44925.10
This article is cited by
-
The anti-tumor function of the IKK inhibitor PS1145 and high levels of p65 and KLF4 are associated with the drug resistance in nasopharyngeal carcinoma cells
Scientific Reports (2019)
-
Whole-Exome Sequencing of Nasopharyngeal Carcinoma Families Reveals Novel Variants Potentially Involved in Nasopharyngeal Carcinoma
Scientific Reports (2019)
-
Expression of EIF5A2 associates with poor survival of nasopharyngeal carcinoma patients treated with induction chemotherapy
BMC Cancer (2016)
-
IKKα-mediated biogenesis of miR-196a through interaction with Drosha regulates the sensitivity of cancer cells to radiotherapy
Cell Death & Differentiation (2016)
-
Epstein–Barr virus latent genes
Experimental & Molecular Medicine (2015)